Piperacillin-tazobactam in intensive care units: a review of population pharmacokinetic analyses

I El-Haffaf, JA Caissy, A Marsot - Clinical pharmacokinetics, 2021 - Springer
Piperacillin-tazobactam is a potent β-lactam/β-lactamase inhibitor antibiotic commonly
prescribed in the intensive care unit setting. Admitted patients often show large variability in …
被引用次数：21 相关文章

Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses

I El-Haffaf, JA Caissy, A Marsot - Clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Piperacillin-tazobactam is a potent β-lactam/β-lactamase inhibitor antibiotic commonly
prescribed in the intensive care unit setting. Admitted patients often show large variability in …

Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses.

I El-Haffaf, JA Caissy, A Marsot - Clinical Pharmacokinetics, 2021 - search.ebscohost.com
Piperacillin-tazobactam is a potent β-lactam/β-lactamase inhibitor antibiotic commonly
prescribed in the intensive care unit setting. Admitted patients often show large variability in …

Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses.

I El-Haffaf, JA Caissy, A Marsot - Clinical Pharmacokinetics, 2021 - europepmc.org
Piperacillin-tazobactam is a potent β-lactam/β-lactamase inhibitor antibiotic commonly
prescribed in the intensive care unit setting. Admitted patients often show large variability in …

Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses

I El-Haffaf, JA Caissy, A Marsot - Clinical Pharmacokinetics, 2021 - search.proquest.com
Piperacillin-tazobactam is a potent β;-lactam/β;-lactamase inhibitor antibiotic commonly
prescribed in the intensive care unit setting. Admitted patients often show large variability in …